Trials / Completed
CompletedNCT01270087
The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Skane University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether anti-inflammatory treatment with adalimumab (Humira) reduces endothelial activation in blood vessels in patients with active rheumatoid arthritis. Markers of endothelial activation are assessed in muscle tissue before treatment and after 3 months, and related to other biomarkers and clinical outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adalimumab | 40 mg IV every 14 days |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2011-01-05
- Last updated
- 2011-01-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01270087. Inclusion in this directory is not an endorsement.